SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000947871-23-000215
Filing Date
2023-02-22
Accepted
2023-02-22 16:30:45
Documents
1
Period of Report
2023-02-17

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 12042
  Complete submission text file 0000947871-23-000215.txt   13358
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address
GORDON CARL L (Reporting) CIK: 0001282930 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39743 | Film No.: 23653625

Mailing Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130 8582994699
Kinnate Biopharma Inc. (Issuer) CIK: 0001797768 (see all company filings)

IRS No.: 824566526 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations